Tyra Biosciences (TYRA) Operating Expenses (2020 - 2026)

For the trailing twelve months through Jun 30, 2026, Operating Expenses at Tyra Biosciences was $160.46 million, up 31.9% year-over-year; for FY2025, it came in at $132.76 million, up 27.4% from FY2024.

• Annual Operating Expenses has increased for five consecutive years, with a five-year compound annual growth rate of 70.2% (FY2020 to FY2025).
• In prior years, Tyra Biosciences' Operating Expenses was $104.18 million in FY2024 (+30.3%), $79.95 million in FY2023 (+35.7%), $58.93 million in FY2022 (+124.2%) and $26.29 million in FY2021 (+182.8%).
• The Q2 2026 figure stands as the highest quarterly Operating Expenses in data going back to Q3 2020.
• On a year-over-year basis, Operating Expenses has increased in each of the last 13 quarters, with growth averaging 29.7% over the last eight quarters.
• The strongest year-over-year quarter for Operating Expenses in the past five years was Q1 2022, with growth of 252.3%; the weakest was Q1 2023, with a decline of 3.4%.
• According to Business Quant data, Operating Expenses for the three prior quarters was $42 million (Q1 2026), $36.52 million (Q4 2025) and $32.94 million (Q3 2025).